Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib With Ifosfamide, Carboplatin, Etoposide in Pediatric Solid Tumors
NCT00788125Phase 2Terminated
- Sponsor
- City of Hope
- Start
- Sep 2008
- Primary completion
- Apr 2010
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dasatinib in solid tumor, sponsored by City of Hope. Started Sep 2008; status: terminated.
02
Drugs
dasatinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00788125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00788125.